Belghiti D, Levy Y, Rifle G, Ottavioli J N, Rickelynck J P, Wolf C, Chalopin J M, Sobel A
Am J Nephrol. 1987;7(1):22-7. doi: 10.1159/000167424.
Idiopathic diffuse crescentic glomerulonephritis without immune deposits is a variant of rapidly progressive glomerulonephritis which can account for up to 40% of crescentic nephritis. The prognosis may depend on both the severity of histological injury at presentation and the efficacy of treatment. Recent advances in therapy have improved the outlook further, and prolonged stable remissions with mild renal failure can occur which contrast with the previously common evolution towards end-stage renal failure within a few weeks. However, relapses in otherwise stable remission may be seen, and we describe a series of 6 acute relapses interrupting such prolonged remissions. The relapses were defined by clinical and histological means. This modification of the natural history of some crescentic glomerulonephritis may reflect new therapeutic strategies, and the relapses may reflect a cyclical nature to the disease evolution which was previously hidden by hemodialysis. The possibility of successive flares suggests that kidney biopsies should be repeated when a rapid deterioration of renal function occurs, since treatment such as high-dose steroids and/or plasma exchange can be again effective if started early.
无免疫沉积物的特发性弥漫性新月体性肾小球肾炎是快速进展性肾小球肾炎的一种变体,可占新月体性肾炎的40%。预后可能取决于就诊时组织学损伤的严重程度以及治疗效果。近年来治疗方法的进展进一步改善了预后,可出现伴有轻度肾衰竭的长期稳定缓解,这与之前几周内常见的进展为终末期肾衰竭形成了对比。然而,在原本稳定的缓解期可能会出现复发,我们描述了一系列6次急性复发打断这种长期缓解的情况。复发通过临床和组织学方法进行定义。一些新月体性肾小球肾炎自然病程的这种改变可能反映了新的治疗策略,而复发可能反映了疾病进展的周期性本质,这种本质以前被血液透析所掩盖。连续发作的可能性表明,当肾功能迅速恶化时应再次进行肾活检,因为如果早期开始使用大剂量类固醇和/或血浆置换等治疗可能再次有效。